Subsidy Information and Financing Scheme SDLPaclitaxel Concentrate For Infusion 150 mg/25 mL, 300 mg/50 mL MSHLPaclitaxel Vial 150 mg/25 mL, 300 mg/50 mL For cancer treatment.
Post Marketing Information DHCPL 13/07/2012 Recall of 2 batches of Anzatax Injection Concentrate 300mg/50ml
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Concentrate For Infusion 150 mg/25 mL KK Women's and Children's Hospital Khoo Teck Puat Hospital Ng Teng Fong General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital Concentrate For Infusion 300 mg/50 mL National Cancer Centre
INTRAVENOUS Select a brand starting with the letter: A C E F G I P ACLIPAK CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ ML [SIN13752P] ANZATAX INJECTION CONCENTRATE 6 MG/ML [SIN09539P] CYTAX PACLITAXEL INJECTION USP CONCENTRATE 6 MG/ ML [SIN15632P] EBETAXEL INJECTION 6MG/ML [SIN13701P] FONKOPAC CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ML [SIN16410P] GENEXOL INJECTION 6 MG/ML [SIN12050P] INTAXEL INJECTION 6 MG/ML [SIN13180P] PACLITAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 6MG/ML [SIN16392P] PACLITAXEL INJECTION 6 MG/ML [SIN14476P] PACLITERO 100 SOLUTION FOR INJECTION 100MG/16.7ML [SIN16436P] See all PACLITERO 30 SOLUTION FOR INJECTION 30MG/5ML [SIN16435P] PACLITERO 300 SOLUTION FOR INJECTION 300MG/50ML [SIN16438P] PAXEL INJECTION 6 MG/ML [SIN14102P]